Biotech Company Says it Complies With Export Controls After its Products Reportedly Linked to Xinjiang
Promega Corp., a U.S. biotechnology company, said it doesn't sell to China’s Xinjiang region. following a report last week that said the company’s products are being used by Xinjiang police (see 2106150055). “Promega does not conduct business in Xinjiang, and…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
we have no customers or distributors there,” a company spokesperson said in a June 16 email. Promega said it “takes seriously its obligation to comply with all applicable U.S. government export controls and sanctions requirements,” including the Entity List, and has “robust procedures and controls that ensure compliance with such requirements.”